Certara Welcomes Dr. Chris Bouton as New Chief Technology Officer

August 1, 2025 - 05:13

RADNOR, Pa., July 31, 2025 — Certara, Inc., a prominent figure in model-informed drug development, has announced the appointment of Dr. Chris Bouton as its new Chief Technology Officer. Dr. Bouton brings a wealth of experience and expertise to the role, having previously held significant positions in leading biotech and pharmaceutical companies. His background in advancing technology and innovation in drug development aligns perfectly with Certara's mission to enhance the efficiency and effectiveness of the drug development process.

In his new position, Dr. Bouton will be responsible for overseeing the company's technological strategy and ensuring that Certara remains at the forefront of scientific advancements. His leadership is expected to drive the development of cutting-edge solutions that support the pharmaceutical industry in bringing new therapies to market more swiftly and safely.

The appointment of Dr. Bouton is seen as a strategic move to bolster Certara's commitment to providing innovative tools and services that empower researchers and clinicians in their quest to improve patient outcomes. The company looks forward to leveraging his vision and expertise to further enhance its offerings in the rapidly evolving landscape of drug development.